LintonPharm
China - GuangzhouBiotechnology
Focus: LintonPharm is a China-based biotechnology company focused on bispecific antibody development for oncology indications. The company operates from Guangzhou with a pipeline concentrated in early-to-mid stage clinical programs.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About LintonPharm
AI assessmentNot HiringNo open roles listed right now. Follow LintonPharm to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Catumaxomab
Bladder CancerClinical Trials (1)
NCT04799847Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
Phase 1/2Help build intelligence for LintonPharm
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.